1-1 of 1
Debra Resta, RN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study of Nilotinib, a Novel Inhibitor of c-Kit, PDGFR, and Bcr-Abl, Administered to Patients with Systemic Mastocytosis.

Andreas Hochhaus, MD, Oliver G. Ottmann, MD, STephanie Lauber, MD, Timothy Hughes, MD, Gregor Verhoef, MD, Anthony P. Schwarer, MD, Alois Gratwohl, MD, Teresa Rafferty, RN, Debra Resta, RN, Norbert Gattermann, MD
Journal: Blood
Blood (2006) 108 (11): 2703.
https://doi.org/10.1182/blood.V108.11.2703.2703
Published: 2006